HomeInsightsPE

Emmessar Biotech & Nutrition Ltd PE Ratio

Emmessar Biotech & Nutrition Ltd PE Ratio

stocks purchased

₹ 0.0 Cr

Volume Transacted

(Dec 11, 2024)

stocks purchased

2.6 K

Stocks Traded

(Dec 11, 2024)

Last Updated on: Dec 11, 2024

Image

Emmessar Biotech & Nutrition Ltd

NSE: EMMESSARBIOTECH

PE

25.4

Last updated on: Dec 11, 2024

Key Highlights

  • The P/E Ratio of Emmessar Biotech & Nutrition Ltd is 25.4 as of 11 Dec 9.00 AM .
  • The P/E Ratio of Emmessar Biotech & Nutrition Ltd changed from 16.7 on March 2019 to 19.8 on March 2024 . This represents a CAGR of 2.88% over 6 years.
  • The Latest Trading Price of Emmessar Biotech & Nutrition Ltd is ₹ 44 as of 11 Dec 15:30 .
  • The PE Ratio of Chemicals Industry has changed from 18.4 to 26.4 in 5 years. This represents a CAGR of 7.49%.
  • The PE Ratio of Automobile industry is 20.3. The PE Ratio of Chemicals industry is 51.6. The PE Ratio of Finance industry is 17.8. The PE Ratio of IT - Software industry is 30.5. The PE Ratio of Retail industry is 157.6. The PE Ratio of Textiles industry is 37.6 in 2024.

Historical P/E Ratio of Emmessar Biotech & Nutrition Ltd

No data available

Company Fundamentals for Emmessar Biotech & Nutrition Ltd

No data available

Image

Emmessar Biotech & Nutrition Ltd

NSE: EMMESSARBIOTECH

Share Price

₹ 44

-0.95 (-2.11%)

stock direction

Last updated on: Dec 11, 2024

Market Price of Emmessar Biotech & Nutrition Ltd

1M

1Y

3Y

5Y

Monitoring Emmessar Biotech & Nutrition Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
11 Dec 202444
10 Dec 202444.95
09 Dec 202444.51
06 Dec 202444.1
05 Dec 202445.43
04 Dec 202446
03 Dec 202446.46
02 Dec 202446.03
29 Nov 202447.61
28 Nov 202445.35

SWOT Analysis Of Emmessar Biotech & Nutrition Ltd

Strength

0

S

Weakness

1

W

Opportunity

0

O

Threats

0

T

BlinkX Score for Emmessar Biotech & Nutrition Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

Asset Value vs Market Value of Emmessar Biotech & Nutrition Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Competitive Comparison of P/E Ratio

Company NamePEMarket Cap (INR Cr.)
Emmessar Biotech & Nutrition Ltd2522
Pidilite Industries Ltd821,62,474
SRF Ltd6169,276
Linde India Ltd13057,935
Gujarat Fluorochemicals Ltd11949,160
Deepak Nitrite Ltd4637,256

Key Valuation Metric of Emmessar Biotech & Nutrition Ltd

No data available

No data available

PE Ratio of Chemicals Industry over time

PE Ratio of Top Sectors

Historical Market Cap of Emmessar Biotech & Nutrition Ltd

No data available

* All values are in crore

Historical Revenue of Emmessar Biotech & Nutrition Ltd

No data available

* All values are in crore

Historical EBITDA of Emmessar Biotech & Nutrition Ltd

No data available

* All values are in crore

Historical Net Profit of Emmessar Biotech & Nutrition Ltd

No data available

* All values are in crore

Historical Dividend Payout of Emmessar Biotech & Nutrition Ltd

No data available

* All values are in %

About Emmessar Biotech & Nutrition Ltd

  • Emmessar Biotech & Nutrition Limited, originally established on 17th March 1992 as Emmessar Chemical Industries Ltd (ECIL) started its operations in manufacturing Super Specialty Fine Chemicals.
  • The Company has so far, succeeded in developing many Specialty Fine Chemicals.
  • ECIL gained official recognition for its R&D from DSIR, Ministry of Science & Technology, Government of India, New-Delhi in early 1996.
  • To better represent its new core activity, a change in the Company name from Emmessar Chemical Industries Ltd (ECIL) to Emmessar Biotech & Nutrition Ltd (EBNL) on April 7, 2000, was made essential. On realizing that some of the specialty chemicals developed & exported to USA & Europe was being used in producing healthcare formulations, the Company plunged into a new venture in the Healthcare business, where phenomenal growth in the coming decades was anticipated.

Emmessar Biotech & Nutrition Ltd News Hub

News

Emmessar Biotech & Nutrition standalone net profit rises 80.00% in the June 2024 quarter

Net profit of Emmessar Biotech & Nutrition rose 80.00% to Rs 0.09 crore in the quarter end...

Read more

2024-08-14 00:00:00

News

Emmessar Biotech & Nutrition to table results

Emmessar Biotech & Nutrition will hold a meeting of the Board of Directors of the Company ...

Read more

2024-08-10 00:00:00

News

Emmessar Biotech & Nutrition schedules AGM

Emmessar Biotech & Nutrition announced that the 32th Annual General Meeting (AGM) of the c...

Read more

2024-09-25 00:00:00

News

Emmessar Biotech & Nutrition to conduct board meeting

Emmessar Biotech & Nutrition will hold a meeting of the Board of Directors of the Company ...

Read more

2024-10-25 00:00:00

Product Composition

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for PE of Emmessar Biotech & Nutrition Ltd

What is the current PE Ratio of Emmessar Biotech & Nutrition Ltd?

The Current PE Ratio of Emmessar Biotech & Nutrition Ltd is 25.43 as on 11 Dec 2024.

What is the average PE Ratio of the Chemicals industry?

The average industry PE Ratio of Chemicals is 51.6 as on 11 Dec 2024.

What was the PE Ratio of Emmessar Biotech & Nutrition Ltd last year?

The PE Ratio of Emmessar Biotech & Nutrition Ltd was 24.55 last year, now the PE ratio is 25.43, showing a year-on-year growth of 3.6%.

What does the PE Ratio of Emmessar Biotech & Nutrition Ltd indicate about its stock?

The PE Ratio of Emmessar Biotech & Nutrition Ltd is 25.43. This ratio indicates that investors are willing to pay 25.43 times the earnings per share for each share of Emmessar Biotech & Nutrition Ltd.

What is the PE Ratio Growth of Emmessar Biotech & Nutrition Ltd in comparison to its Earnings per Share (EPS) growth rate?

The PE Ratio of Emmessar Biotech & Nutrition Ltd grew by 3.6% whereas, the EPS ratio grew by 211.1.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Demat Account
Verify your phone
+91
*By signing up you agree to our terms & conditions